Literature DB >> 21299467

Redox-regulated peptide transfer from the transporter associated with antigen processing to major histocompatibility complex class I molecules by protein disulfide isomerase.

Kwangmin Cho1, Sunglim Cho, Seong-Ok Lee, Changhoon Oh, Kwonyoon Kang, Jeongmin Ryoo, Sungwook Lee, Seongman Kang, Kwangseog Ahn.   

Abstract

Most antigenic peptides are generated by proteasomes in the cytosol and are transported by the transporter associated with antigen processing (TAP) into the endoplasmic reticulum, where they bind with nascent major histocompatibilitiy complex class I molecule (MHC-I). Although the overall process of peptide-MHC-I complex assembly is well studied, the mechanism by which free peptides are delivered from TAP to MHC-I is unknown. In this study, we investigated the possible role of protein disulfide isomerase (PDI) as a peptide carrier between TAP and MHC-I. Analysis of PDI-peptide complexes reconstituted in vitro showed that PDI exhibits some degree of specificity for peptides corresponding to antigenic ligands of various human leukocyte antigen (HLA) alleles. Mutations of either anchor residues of the peptide ligand or the peptide-binding site of PDI inhibited the PDI-peptide interaction. The PDI-peptide interaction increased under reducing conditions, whereas binding of the peptide to PDI decreased under oxidizing conditions. TAP-associated PDI was predominantly present in the reduced form, whereas the MHC-I-associated PDI was present in the oxidized form. Further, upon binding of optimal peptides, PDI was released from TAP and sequentially associated with HLA-A2.1. Our data revealed a redox-regulated chaperone function of PDI in delivering antigenic peptides from TAP to MHC-I.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21299467     DOI: 10.1089/ars.2010.3756

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

Review 1.  Endoplasmic reticulum-dependent redox reactions control endoplasmic reticulum-associated degradation and pathogen entry.

Authors:  Christopher P Walczak; Kaleena M Bernardi; Billy Tsai
Journal:  Antioxid Redox Signal       Date:  2012-01-30       Impact factor: 8.401

Review 2.  Nox NADPH oxidases and the endoplasmic reticulum.

Authors:  Francisco R M Laurindo; Thaís L S Araujo; Thalita B Abrahão
Journal:  Antioxid Redox Signal       Date:  2014-02-26       Impact factor: 8.401

3.  Human protein-disulfide isomerase is a redox-regulated chaperone activated by oxidation of domain a'.

Authors:  Chao Wang; Jiang Yu; Lin Huo; Lei Wang; Wei Feng; Chih-chen Wang
Journal:  J Biol Chem       Date:  2011-11-16       Impact factor: 5.157

4.  The nairovirus nairobi sheep disease virus/ganjam virus induces the translocation of protein disulphide isomerase-like oxidoreductases from the endoplasmic reticulum to the cell surface and the extracellular space.

Authors:  Lidia Lasecka; Michael D Baron
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

Review 5.  PDI Family Members as Guides for Client Folding and Assembly.

Authors:  Shingo Kanemura; Motonori Matsusaki; Kenji Inaba; Masaki Okumura
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

6.  Proteomics Analysis of Aqueous Humor and Rejected Graft in Pig-to-Non-Human Primate Corneal Xenotransplantation.

Authors:  Jae Won Oh; Chang Ho Yoon; Jin Suk Ryu; Kwang Pyo Kim; Mee Kum Kim
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

Review 7.  The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.

Authors:  Michael L Salmans; Fang Zhao; Bogi Andersen
Journal:  Breast Cancer Res       Date:  2013-04-24       Impact factor: 6.466

8.  Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state.

Authors:  Rashed Alhammad; Sasiprapa Khunchai; Nopprarat Tongmuang; Thawornchai Limjindaporn; Pa-Thai Yenchitsomanus; Luciano Mutti; Marija Krstic-Demonacos; Constantinos Demonacos
Journal:  Oncol Rep       Date:  2020-10-20       Impact factor: 3.906

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.